We use cookies for a better user experience. Read our Privacy Policy
I AgreeComplement deficiency refers to a suboptimal functioning or immunodeficiency of absent of one of the complement system proteins in the body. Many of the complement disorders are never detected as there are redundancies in the immune system. A few of the studies make an estimation that nearly less than 10% of such disorders are ever detected. However, when any such disorder is suspected, laboratory testing for the identification of complement dysregulation and deficiency is started with AH50 and CH50. The outcome of the testing are then investigated so as to underscore the ways for activation of pathways, which are usually affected. Increased demand for these tests is estimated to support growth of the global complement deficiency tests market over the tenure of analysis, from 2020 to 2030.
Type, application, and region are the three important parameters based on which the global Complement Deficiency Tests Market has been classified.
One of the relevant and important developments of the market that gives a quick view of the dynamics pertaining to global complement deficiency tests market is mentioned as below:
Some of the prominent organizations in the global complement deficiency tests market comprise the below-mentioned:
The global complement deficiency tests market is characterized by the presence of the following restraints, drivers, and opportunities.
Complement refers to a class of serum glycoprotein, which is an element of natural immune system. It improves the capabilities of macrophages and antibodies so as to clear pathogens and damaged cells. Complement also improves inflammation and assists in the enhancement of the response of the immune system. It is with the help of a cascade, the complement system is activated. Complement deficiency is basically an elementary immunodeficiency disorder. Sepsis, infections, and immunosuppression are resultants of deficiency of any component of complement. The global complement deficiency tests market is likely to be influenced by the rising incidences of illnesses pertaining to this deficiency.
Episodes of angioedema or autoimmune disease and bacterial infection are clinical indications for complement deficiency. This deficiency is either acquired or inherited and it can also be either partial or complete. There has been an increased prevalence of autoimmune diseases, such as cryoglobulinemia, Rheumatoid Arthritis, and Systemic Lupus Erythematous. In accordance with the data of American Autoimmune Related Diseases Association (AARDA),, nearly 50 million people in America are plagued with autoimmune diseases. Such high prevalence of the disease is estimated to support growth of the global complement deficiency tests market over the tenure of assessment, from 2020 to 2030.
Driven by the high prevalence of autoimmune diseases, North America is likely o remain at the forefront of the growth of the global complement deficiency tests market. In addition, augmented awareness about the medical conditions and availability of new technologies is anticipated to work in favor of the complement deficiency tests market in North America.
Asia Pacific is likely to rise to be one of the most promising markets for the region. The growth of the market in the region is attributed to the rising prevalence of developing infrastructure of the research sector, autoimmune diseases, chronic diseases, and propensity of people to spend in new medical technologies.
Interested in this report?
Get a FREE Brochure now!
*Get Brochure (PDF) sent to your email within minutes
N/A
Complete the form below and we'll get back to you shortly.